RPRX vs WPM

For growth investors, Wheaton Precious Metals Corp.

(WPM) is the stronger pick with 83. 3% revenue growth year-over-year, versus 5. 1% for Royalty Pharma plc (RPRX). Royalty Pharma plc (RPRX) offers the better valuation at 27. 9x trailing P/E (9. 9x forward), making it the more compelling value choice. Analysts rate Royalty Pharma plc (RPRX) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Royalty Pharma plc (RPRX) is the cheapest at 27.

9x versus Wheaton Precious Metals Corp. at 40. 0x. On forward P/E, Royalty Pharma plc is actually cheaper at 9. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Wheaton Precious Metals Corp. wins at 1. 07x versus Royalty Pharma plc's 1. 40x — a reasonable growth-adjusted valuation.

Over the past 5 years, Wheaton Precious Metals Corp.

(WPM) delivered a total return of +207. 9%, compared to +32. 4% for Royalty Pharma plc (RPRX). Over 10 years, the gap is even starker: WPM returned +689. 7% versus RPRX's +24. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Royalty Pharma plc (RPRX) is the lower-risk stock at 0.

43β versus Wheaton Precious Metals Corp. 's 0. 78β — meaning WPM is approximately 81% more volatile than RPRX relative to the S&P 500. On balance sheet safety, Wheaton Precious Metals Corp. (WPM) carries a lower debt/equity ratio of 0% versus 92% for Royalty Pharma plc — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Wheaton Precious Metals Corp.

(WPM) is pulling ahead at 83. 3% versus 5. 1% for Royalty Pharma plc (RPRX). On earnings-per-share growth, the picture is similar: Wheaton Precious Metals Corp. grew EPS 181. 2% year-over-year, compared to -5. 8% for Royalty Pharma plc. Over a 3-year CAGR, WPM leads at 30. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Wheaton Precious Metals Corp.

(WPM) is the more profitable company, earning 63. 6% net margin versus 32. 4% for Royalty Pharma plc — meaning it keeps 63. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: WPM leads at 68. 8% versus 65. 6% for RPRX. At the gross margin level — before operating expenses — RPRX leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Wheaton Precious Metals Corp. (WPM) is the more undervalued stock at a PEG of 1. 07x versus Royalty Pharma plc's 1. 40x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Royalty Pharma plc (RPRX) trades at 9. 9x forward P/E versus 24. 2x for Wheaton Precious Metals Corp. — 14. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for WPM: 15. 9% to $152. 50.

All stocks in this comparison pay dividends.

Royalty Pharma plc (RPRX) offers the highest yield at 1. 3%, versus 0. 5% for Wheaton Precious Metals Corp. (WPM).

For long-horizon retirement investors, Wheaton Precious Metals Corp.

(WPM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 78), 0. 5% yield, +689. 7% 10Y return). Both have compounded well over 10 years (WPM: +689. 7%, RPRX: +24. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (RPRX (Healthcare) and WPM (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: RPRX is a mid-cap quality compounder stock; WPM is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.